These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2216206)

  • 1. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function.
    Wurtzel D
    Obstet Gynecol; 1990 Oct; 76(4):689-92. PubMed ID: 2216206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor.
    Butler-O'Hara M; D'Angio CT
    J Perinatol; 2002; 22(7):541-6. PubMed ID: 12368969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous indomethacin and changes of renal function in premature infants with patent ductus arteriosus.
    John EG; Vasan U; Hastreiter AR; Bhat R; Evans MA
    Pediatr Pharmacol (New York); 1984; 4(1):11-9. PubMed ID: 6739182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
    Betkerur MV; Yeh TF; Miller K; Glasser RJ; Pildes RS
    Pediatrics; 1981 Jul; 68(1):99-102. PubMed ID: 6909683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
    Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
    Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency.
    Gloor JM; Muchant DG; Norling LL
    J Perinatol; 1993; 13(6):425-7. PubMed ID: 8308583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of aggressive tocolysis for preterm labor with advanced cervical dilatation.
    Psomiadis N; Goldkrand J
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):47-52. PubMed ID: 16105791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal renal impairment after indomethacin tocolysis.
    Walker MP; Cantrell CJ
    J Perinatol; 1993; 13(6):461-3. PubMed ID: 8308589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study.
    Morales WJ; Smith SG; Angel JL; O'Brien WF; Knuppel RA
    Obstet Gynecol; 1989 Oct; 74(4):567-72. PubMed ID: 2677863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin tocolysis and white matter injury in preterm infants.
    Friedman S; Flidel-Rimon O; Steinberg M; Shinwell ES
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):87-91. PubMed ID: 16203592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis.
    Doyle NM; Gardner MO; Wells L; Qualls C; Papile LA
    J Perinatol; 2005 May; 25(5):336-40. PubMed ID: 15861198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The controversy surrounding indomethacin for tocolysis.
    Macones GA; Marder SJ; Clothier B; Stamilio DM
    Am J Obstet Gynecol; 2001 Feb; 184(3):264-72. PubMed ID: 11228471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of long-term tocolysis with indomethacin.
    Gerson A; Abbasi S; Johnson A; Kalchbrenner M; Ashmead G; Bolognese R
    Am J Perinatol; 1990 Jan; 7(1):71-4. PubMed ID: 2294913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function in SFD and AFD preterm babies.
    Narang A; Bhakoo ON; Majumdar S; Kumar CH
    Indian Pediatr; 1993 Feb; 30(2):201-5. PubMed ID: 8375882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study.
    How HY; Zafaranchi L; Stella CL; Recht K; Maxwell RA; Sibai BM; Spinnato JA
    Am J Obstet Gynecol; 2006 Apr; 194(4):976-81. PubMed ID: 16580286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tocolysis and its place in premature labor].
    Stoĭkov S; Popov I
    Akush Ginekol (Sofiia); 1999; 38(1):11-3. PubMed ID: 11965710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function and effect of aminoglycoside therapy during the first ten days of life.
    Giapros VI; Andronikou SK; Cholevas VI; Papadopoulou ZL
    Pediatr Nephrol; 2003 Jan; 18(1):46-52. PubMed ID: 12488990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant.
    van den Anker JN; Hop WC; de Groot R; van der Heijden BJ; Broerse HM; Lindemans J; Sauer PJ
    Pediatr Res; 1994 Nov; 36(5):578-81. PubMed ID: 7877874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocolytic indomethacin: effects on neonatal haemodynamics and cerebral autoregulation in the preterm newborn.
    Baerts W; van Bel F; Thewissen L; Derks JB; Lemmers PM
    Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F419-23. PubMed ID: 23482639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.